Medications

Experimental diabetes drug makes comeback

A panel of federal health advisers has backed the benefits of an experimental diabetes drug that uses a new method to reduce blood sugar, setting aside previous concerns about the pill's safety.

Medications

Britain bans herbal drug khat

British Home Secretary Theresa May on Wednesday announced a ban on the herbal stimulant khat, going against the advice of her own experts who said such a move was disproportionate.

Medications

FDA panel narrowly backs Cempra antibiotic

A panel of federal health advisers has narrowly recommended approval for an experimental antibiotic from Cempra Inc., a small North Carolina drugmaker.

Medications

Zydelig approved for three types of blood cancer

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Diseases, Conditions, Syndromes

Fatality rates are high within two years of drug-induced liver injury

Most patients suffering liver toxicity due to medications or herbal or dietary supplements recover from the acute liver injury without long-term problems, but some do not survive the injury or they require liver transplantation. ...

page 5 from 6